A Study to Investigate the Safety and Efficacy of Atezolizumab in Previously-Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Clinical trial NCT03922997 · COMPLETED
Trial details
- NCT number
- NCT03922997
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-03
- Primary completion
- 2022-08-11
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.